JOURNAL ARTICLE

University Department of Pharmacology Reports Findings in Drug Research (Neuropsychopharmacology of hallucinogenic and non-hallucinogenic 5-HT2A receptor agonists).

  • Published In: Psychology & Psychiatry Journal, 2025. P. 599 1 of 2

  • Database: Psychology Source 2 of 2

Abstract

The article discusses recent research on the therapeutic potential of psychedelic drugs, such as LSD and psilocin, which have gained renewed interest in psychiatry due to evidence of their effectiveness in treating various mental illnesses, including major depression and anxiety disorders. Historically marginalized due to their association with counterculture and legal restrictions, these substances are now being studied for their neuropsychopharmacological properties, particularly their interaction with 5-HT receptors. The research highlights the emergence of a new class of 5-HT receptor agonists that may offer therapeutic benefits without the hallucinatory effects typically associated with psychedelics. The findings suggest a promising avenue for novel drug treatments in psychiatry. [Extracted from the article]

Additional Information

  • Source:Psychology & Psychiatry Journal. 2025/06, p599
  • Document Type:Article
  • Subject Area:Music
  • Publication Date:2025
  • ISSN:1944-2718
  • Accession Number:185535244
  • Copyright Statement:Copyright of Psychology & Psychiatry Journal is the property of NewsRx and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.